The Blood Sugar Connection Nobody Told You About (It’s Magnesium)

As an RDH, I’ve witnessed firsthand how patients can struggle with the metabolic merry-go-round.

HbA1c creeps up. Periodontal status worsens. You educate, you treat, you refer. The systemic inflammation in their tissues mirrors the systemic inflammation in their bloodwork. The two conditions  periodontal disease and diabetes, feed each other in a bidirectional loop that’s been documented in the literature for decades.

But there’s a third player in this relationship that rarely makes it into the conversation.

Magnesium sits at the intersection of glucose metabolism, insulin signaling, and inflammatory burden. And the relationship between magnesium status and blood sugar control is not peripheral; it is mechanistically central.

Here’s what the research shows.

---

The Vicious Cycle You Need to Understand

Let’s start with the loop, because it’s important to see this as a dynamic system rather than a static deficiency.

Step 1: A person consumes a diet low in magnesium (very common in Western eating patterns heavy on refined carbohydrates and processed foods and low in whole grains, legumes, and leafy greens).

Step 2: Intracellular magnesium levels drop. Even if serum magnesium looks normal on a standard lab panel, cellular magnesium is low, and cellular magnesium is what actually matters for insulin signaling.

Step 3: Low intracellular magnesium impairs tyrosine kinase activity at the insulin receptor. This is the molecular handshake that must occur for insulin to deliver its signal into the cell. Without adequate magnesium, the receptor can hear insulin knock but can’t properly open the door.

Step 4: Postreceptor insulin signaling is compromised. Glucose transport into cells is impaired. Blood glucose rises.

Step 5: Hyperglycemia triggers osmotic diuresis  the kidneys start excreting more magnesium in the urine to handle the glucose load.

Step 6: Magnesium depletion deepens. Insulin resistance worsens. HbA1c climbs. And the cycle accelerates.

This loop is not theoretical. It’s documented in the clinical literature and confirmed by multiple lines of evidence: epidemiological, mechanistic, and interventional.

---

The Serum Magnesium Trap

Here is a critical distinction that changes how you read patients’ lab work.

When healthcare providers check magnesium levels which, to be honest, doesn’t happen as routinely as it should, they typically measure serum total magnesium. This is the magnesium circulating in the blood.

The problem: serum magnesium is tightly regulated by the kidneys and bone as a reserve. The body prioritizes keeping serum levels stable even when total body magnesium is depleted. You can be running a chronic intracellular magnesium deficit with measurable impairments in insulin signaling and cellular metabolism while your serum magnesium level looks perfectly normal.

A 2015 review published in the World Journal of Diabetes was explicit about this: patients with type 2 diabetes often exhibit lower cellular and/or ionized plasma magnesium concentrations despite normal total serum Mg levels. The authors called this chronic latent magnesium deficit a common finding in diabetic patients, particularly those with poorly controlled glycemic profiles.

The takeaway for clinical practice: a “normal” serum magnesium in your diabetic patient does not mean adequate magnesium status. The cellular picture is a different story.

[Source: Barbagallo M, Dominguez LJ. “Magnesium and type 2 diabetes.” World Journal of Diabetes. 2015. DOI: 10.4239/wjd.v6.i10.1152]

---

The Tyrosine Kinase Mechanism: Why This Matters for Every Cell

Let’s go one layer deeper on the insulin receptor, because this is where the mechanism becomes undeniable.

The insulin receptor is a tyrosine kinase receptor. When insulin binds to it, the receptor phosphorylates itself on tyrosine residues  it self-activates and then cascades a signal into the cell that ultimately leads to GLUT4 glucose transporters being moved to the cell surface to pull glucose in.

Magnesium is required for this phosphorylation step. The MgATP complex is the substrate for virtually every kinase reaction in the body, including the insulin receptor’s self-activation. Without adequate intracellular magnesium, the kinase function is defective; the receptor is there, insulin is there, but the activation signal is muted.

The World Journal of Diabetes review described it precisely: reduced intracellular Mg concentrations result in defective tyrosine kinase activity and postreceptor impairment in insulin action, ultimately worsening insulin resistance in diabetic patients.

This isn’t a minor inefficiency. When insulin signaling is impaired at the receptor level, every downstream process that depends on it is compromised: glucose uptake, glycogen synthesis, lipogenesis, protein synthesis, and anti-inflammatory signaling. The whole metabolic program runs less efficiently.

---

What the Human Data Shows

The epidemiological picture is consistent and strong.

Studies show an inverse relationship between magnesium intake and the risk of developing type 2 diabetes, meaning higher magnesium intake is associated with lower diabetes risk. This holds across multiple large cohort studies. A lower dietary magnesium intake has been identified as a risk factor for both type 2 diabetes and metabolic syndrome.

A 2022 study in Maedica added important clinical detail: in 200 newly diagnosed T2DM patients, those with low serum magnesium had significantly higher fasting blood sugar, higher postprandial blood sugar, higher HbA1c, higher serum insulin levels, and higher HOMAIR (the standard measure of insulin resistance). The correlation between magnesium and HOMAIR was strongly negative (r = 0.819), meaning as magnesium went down, insulin resistance went up, in a tight, consistent relationship.

The authors of that study concluded that serum magnesium level should be included as a routine assessment in patients with diabetes mellitus. That’s a meaningful clinical recommendation from researchers who studied it directly.

[Source: Kuppusamy S et al. “Association of Serum Magnesium with Insulin Indices in Patients with Type 2 Diabetes Mellitus.” Maedica. 2022. DOI: 10.26574/maedica.2022.17.3.596]

---

Supplementation: What the RCTs Actually Show

A systematic review and meta-analysis of 18 double-blind randomized controlled trials, summarized in the Cureus comprehensive review, found that magnesium supplementation had beneficial effects on glucose parameters in individuals with T2DM and improved insulin sensitivity parameters in those at high risk.

Key findings from the supplementation literature:

• Improvements in fasting blood glucose, postprandial blood glucose, and HbA1c have been documented in most, though not all, trials
• Insulin sensitivity measures, including HOMAIR, improved with supplementation in multiple studies
• The effect is most consistent in patients with documented low dietary magnesium intake and those with poorly controlled glycemia
• The Cureus umbrella review confirmed an inverse association between elevated magnesium intake and T2DM risk

The dosage range studied for metabolic health: 300–600 mg/day over 3–6 months. Longer durations appear to produce more pronounced effects on metabolic markers.

An important nuance: not every trial shows consistent results. The heterogeneity in study populations, baseline magnesium status, form of supplementation, and duration makes it hard to issue a blanket statement. What the weight of the evidence supports is this: for patients with low dietary magnesium who have T2DM or are at risk, addressing the deficiency is a low-risk, cost-effective, and biologically meaningful intervention.

[Source: Al Alawi et al., Cureus, 2024  DOI: 10.7759/cureus.71392]

---

The Inflammation Thread: Where Diabetes, Periodontics, and Magnesium Converge

Here is the convergence point that, as a dental hygienist, I need you to really sit with.

Magnesium deficiency produces the same inflammatory profile that we see in both poorly controlled diabetes and in active periodontal disease:

• Elevated CRP
• Elevated IL6
• Elevated TNFα
• Elevated oxidative stress markers
• Reduced glutathione (antioxidant defense)

These are not parallel pathways that happen to use the same molecules. They are the same pathway  chronic, lowgrade systemic inflammation driven by a nutrient deficit, expressing itself simultaneously in the periodontium, in the vasculature, and in the pancreatic beta cells trying to maintain insulin output under duress.

The 2015 World Journal of Diabetes review made this connection directly: low Mg intake has been related to the development of type 2 diabetes and metabolic syndrome,  and the mechanism runs through inflammation and oxidative stress just as much as it runs through insulin receptor signaling.

Our diabetic patients don’t have three separate problems: bad blood sugar, inflamed gums, and systemic inflammation. They have one problem expressing itself in three places. And magnesium is a thread running through all three.

---

The Urinary Loss Problem: Why Diabetic Patients Can’t Hold On

One more mechanism worth understanding: the body’s ability to retain magnesium is compromised in diabetes in ways that go beyond just low intake.

Hyperglycemia produces osmotic diuresis; the kidneys flush more fluid when blood glucose is high, and magnesium goes with it. The higher the blood sugar, the more magnesium is lost in the urine.

Additionally, hyperinsulinemia elevated insulin, a hallmark of insulin-resistant states before frank diabetes has been shown to disrupt magnesium transport across cell membranes. The mechanism that moves magnesium into cells requires insulin signaling to function properly. When that signaling is impaired, magnesium doesn’t get into the cells that need it.

The result: a diabetic patient can be eating reasonable amounts of dietary magnesium and still running a chronic cellular deficit, because hyperglycemia is flushing it out and insulin resistance is keeping it out of the cells. Absorption and retention remain relatively intact, but the excretion and transport problems overwhelm them.

This is why the World Journal of Diabetes review identified low dietary magnesium intake and increased urinary magnesium loss as the two most important mechanisms favoring magnesium depletion in T2DM patients and why they called dietary magnesium supplementation a “nonpharmacologic, cost-effective, and safe approach” for T2DM prevention and management.

---

The Dental Hygiene Lens: What We See and What We Can Do

Our diabetic patients are among our most complex recalls. We know the bidirectional relationship: uncontrolled periodontal disease raises HbA1c, and elevated HbA1c worsens periodontal outcomes. We know the inflammatory burden goes both ways.

What we can add to this picture now:

Assess for the magnesium deficiency profile. The diabetes patient is taking metformin  which has been associated with altered magnesium metabolism. The patient on diuretics for hypertension comorbid with their diabetes. The patient whose diet is primarily processed, lowfiber, low-vegetable foods (which, let’s be honest, is a significant portion of our diabetic population). These are the patients most likely running low.

Name the connection. Not in a way that overstates what we know or strays outside our scope  but in a way that’s genuinely useful. “Your body needs magnesium to respond to insulin effectively, and most people with diabetes are running low. That’s worth bringing up with your doctor or dietitian.” That’s a sentence that could change what happens at their next primary care appointment.

Document and refer. If you’re seeing recalcitrant perio in a diabetic patient, document the dietary pattern, note the medications that may be contributing to depletion, and recommend appropriate followup. You’re not diagnosing or treating. You’re connecting dots that too few clinicians connect.

---

Practical Guidance

For patients interested in addressing dietary magnesium:

• Best food sources for people managing blood sugar: pumpkin seeds, almonds, spinach, black beans, quinoa  all low to moderate glycemic index, no blood sugar spikes
• Supplementation range for metabolic health: 300–600 mg/day, magnesium glycinate or citrate preferred for bioavailability
• Duration: 3–6 months to begin seeing improvements in glucose parameters; ongoing for sustained benefit
• Important: patients on medications for diabetes, hypertension, or kidney disease should discuss supplementation with their physician before starting; magnesium interacts with several medication classes and renal clearance is the primary excretion route

---

Next Up

Article 4 closes the series with the piece I think will surprise the most people: the magnesium-brain connection. Depression, anxiety, chronic stress, insomnia, and the NMDA receptor story that links nutritional status directly to how the nervous system regulates mood.

Spoiler: some of the most common antidepressants appear to work, in part, by raising intracellular magnesium.

---

Content is educational and not intended as individualized medical advice.

Disclosure: I partner with Equilife because I use and trust their formulations. Commission may be earned at no additional cost to you.

---

The Science

Based on research retrieved from PubMed:

1. Al Alawi AM et al. “Magnesium Matters.” Cureus. 2024. DOI: 10.7759/cureus.71392

2. Barbagallo M, Dominguez LJ. “Magnesium and type 2 diabetes.” World Journal of Diabetes. 2015. DOI: 10.4239/wjd.v6.i10.1152

3. Kuppusamy S et al. “Association of Serum Magnesium with Insulin Indices in Patients with Type 2 Diabetes Mellitus.” Maedica. 2022. DOI: 10.26574/maedica.2022.17.3.596

---

Amber Auger, MPH, RDH  Functional Hygienist, clinician, and advocate for whole-person health.